Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella

More documents

Recommendations

Info

Vasopressori Strategia di ricerca PubMed Progetto LaSER. Lotta alla sepsi in Emilia-Romagna Allegati (“Catecholamines/administration and dosage”[MeSH] OR “Catecholamines/adverse effects”[MeSH] OR “Catecholamines/drug effects”[MeSH] OR “Catecholamines/pharmacology”[MeSH] OR “Catecholamines/therapeutic use”[MeSH] OR “Catecholamines/therapy”[MeSH] OR “Catecholamines/toxicity”[MeSH]) AND (sepsis[text] OR “septic shock”[text]) AND (((“outcome and process assessment (health care)”[TIAB] NOT Medline[SB]) OR “outcome and process assessment (health care)”[MeSH Terms] OR Outcome and Process Assessment[Text Word]) OR (“clinical protocols”[MeSH Terms] OR Clinical Protocols[Text Word]) OR (“comparative study”[MeSH Terms] OR Comparative Study[Text Word]) OR (“practice guideline”[Publication Type] OR “practice guidelines”[MeSH Terms] OR “practice guideline”[Text Word]) OR (“controlled clinical trial”[Publication Type] OR “controlled clinical trials”[MeSH Terms] OR “controlled clinical trials”[Text Word]) OR (“randomized controlled trial”[Publication Type] OR “randomized controlled trials”[MeSH Terms] OR “randomized controlled trials”[Text Word]) OR (“metaanalysis”[Publication Type] OR “meta-analysis”[MeSH Terms] OR “meta-analysis”[Text Word]) OR (“review”[Publication Type] OR “review literature”[MeSH Terms] OR “review”[Text Word]) OR (“endpoint determination”[MeSH Terms] OR Endpoint Determination[Text Word])) AND (“2004/01/01”[PDAT] : “2006/06/01”[PDAT]) AND hasabstract[text] AND “humans”[MeSH Terms] Risultati della ricerca PubMed • Albanese J., Leone M., Delmas A., Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med, 33 (9): 1897-1902, Sep 2005. PMID: 16148457 [PubMed - indexed for MEDLINE] • Asfar P., Hauser B., Radermacher P., Matejovic M. Catecholamines and vasopressin during critical illness. Crit Care Clin, 22 (1): 131-149, vii-viii, Jan 2006. Review. PMID: 16399024 [PubMed - indexed for MEDLINE] • Beale R.J., Hollenberg S.M., Vincent J.L., Parrillo J.E. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med, 32 (11 Suppl): S455-S465, Nov 2004. Review. PMID: 15542956 [PubMed - indexed for MEDLINE] • Beck G., Hanusch C., Brinkkoetter P., Rafat N., Schulte J., van Ackern K., Yard B. [Effects of dopamine on cellular and humoral immune responses in septic patients]. Anaesthesist, 54 (10): 1012-1020, Oct 2005. Review. German. PMID: 15997388 [PubMed - indexed for MEDLINE] • Beck G.Ch., Brinkkoetter P., Hanusch C., Schulte J., van Ackern K., van der Woude F.J., Yard B.A. Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care, 8 (6): 485-491, Dec 2004. Epub 3 Jun 2004. Review. PMID: 15566620 [PubMed - indexed for MEDLINE] Dossier 143 72
Progetto LaSER. Lotta alla sepsi in Emilia-Romagna Allegati • Delmas A., Leone M., Rousseau S., Albanese J., Martin C. Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care. 9 (2): 212-222, Apr 2005. Epub 9 Sep 2004. Review. PMID: 15774080 [PubMed - indexed for MEDLINE] • den Ouden D.T., Meinders A.E. Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review. Neth J Med, 63 (1): 4-13, Jan 2005. Review. PMID: 15719846 [PubMed - indexed for MEDLINE] • Duenser M.W., Hasibeder W.R. Dear vasopressin, where is your place in septic shock? Crit Care, 9 (2): 134-135, Apr 2005. Epub 15 Nov 2004. PMID: 15774061 [PubMed - indexed for MEDLINE] • Felten M.L., Cosson C., Charpentier J., Paradis V., Benhamou D., Mazoit J.X., Edouard A.R. Effect of isoproterenol on the cardiac troponin I degradation and release during early TNFalpha-induced ventricular dysfunction in isolated rabbit heart. J Cardiovasc Pharmacol, 44 (5): 532-538, Nov 2004. PMID: 15505489 [PubMed - indexed for MEDLINE] • Groeben H., Bottiger B.W., Schafer M., Heine J. [Catecholamine-resistant hypotension. An update. Anasthesiol Intensivmed Notfallmed Schmerzther, 40 (7): 412-418, Jul 2005. Review. German. PMID: 16001320 [PubMed - indexed for MEDLINE] • Hall L.G., Oyen L.J., Taner C.B., Cullinane D.C., Baird T.K., Cha S.S., Sawyer M.D. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy, 24 (8): 1002-1012, Aug 2004. PMID: 15338849 [PubMed - indexed for MEDLINE] • Hernandez G., Bruhn A., Romero C., Javier Larrondo F., De La Fuente R., Castillo L., Bugedo G. Implementation of a norepinephrine-based protocol for management of septic shock: a pilot feasibility study. J Trauma, 60 (1): 77-81, Jan 2006. PMID: 16456439 [PubMed - indexed for MEDLINE • Hernandez G., Bruhn A., Romero C., Javier Larrondo F., De La Fuente R., Castillo L., Bugedo G. Management of septic shock with a norepinephrine-based haemodynamic algorithm. Resuscitation, 66 (1): 63-69, Jul 2005. PMID: 15993731 [PubMed - indexed for MEDLINE] • Holmes C.L. Vasoactive drugs in the intensive care unit. Curr Opin Crit Care, 11 (5): 413-417, Oct 2005. Review. PMID: 16175026 [PubMed - indexed for MEDLINE • Lemaire L.C., de Kruif M.D., Giebelen I.A., Levi M., van der Poll T., Heesen M. Dobutamine does not influence inflammatory pathways during human endotoxemia. Crit Care Med, 34 (5): 1365-1371, May 2006. PMID: 16540959 [PubMed - indexed for MEDLINE] • Levy B., Dusang B., Annane D., Gibot S., Bollaert P.E., College Interregional des Reanimateurs du Nord-Est. Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study. Crit Care Med, 33 (10): 2172-2177, Oct 2005a. PMID: 16215366 [PubMed - indexed for MEDLINE] Dossier 143 73
Page 1:
143- 2007 Progetto LaSER Lotta alla
Page 4 and 5:
Il documento è stato redatto da Ma
Page 7:
Sommario Progetto LaSER. Lotta alla
Page 10 and 11:
1.2. Gli strumenti Progetto LaSER.
Page 12 and 13:
Progetto LaSER. Lotta alla sepsi in
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Figura 2. Storia naturale della sep
Page 22 and 23:
Page 24 and 25: La sepsi Cause Progetto LaSER. Lott
Page 27 and 28: Progetto LaSER. Lotta alla sepsi in
Page 35 and 36: 3.2. Diagnosi Progetto LaSER. Lotta
Page 39 and 40: 3.4. Antibioticoterapia Progetto La
Page 53 and 54: Raccomandazione Progetto LaSER. Lot
Page 55: Allegati Progetto LaSER. Lotta alla
Page 60 and 61: Tabella A.1. Risultati degli studi
Page 65 and 66: Allegato B. Glossario Progetto LaSE
Page 71 and 72: Fluidoterapia Strategia di ricerca
Page 73: Progetto LaSER. Lotta alla sepsi in
Page 99 and 100: Proteina C attivata Strategia di ri
Page 101: Progetto LaSER. Lotta alla sepsi in
Page 109 and 110: COLLANA DOSSIER a cura dell’Agenz
Page 111 and 112: 39. Rapporti tecnici della Task For
Page 113 and 114: 82. Applicazione del DLgs 626/94 in
Page 115: 125. Il clima organizzativo nelle A
show all

Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella

Create successful ePaper yourself

Delete template?

Save as template?